Dereje Jima

Dr. Dereje Jima


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CLCassandra Love
Cassandra Love
ZSZhen Sun
Zhen Sun
DJDereje Jima
Dereje Jima
GLGuojie Li
Guojie Li
JZJenny Zhang
Jenny Zhang
SDSandeep S Dave
Sandeep S Dave

4 January 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JZJenny Zhang
Jenny Zhang
VGVladimir Grubor
Vladimir Grubor
CLCassandra L. Love
Cassandra L. Love
ABAnjishnu Banerjee
Anjishnu Banerjee
KRKristy L. Richards
Kristy L. Richards
SDSandeep S. Dave
Sandeep S. Dave
Diffuse large B-cell lymphoma (DLBCL) is the most common form of lymphoma in adults. The disease exhibits a striking heterogeneity in gene expression profiles and clinical outcomes, but its genetic causes remain to be fully defined. Through whole genome and exome sequencing, we characterized the genetic diversity of DLBCL. In all, we sequenced 73 DLBCL primary tumors (34 with matched normal DNA). Separately, we sequenced the exomes of 21 DLBCL cell lines. We identified 322 DLBCL cancer genes that were recurrently mutated in primary DLBCLs. We identified recurrent mutations implicating a number of known and not previously identified genes and pathways in DLBCL including those related to chromatin modification ( ARID1A and MEF2B ), NF-κB ( CARD11 and TNFAIP3 ), PI3 kinase ( PIK3CD , PIK3R1 , and MTOR ), B-cell lineage ( IRF8 , POU2F2 , and GNA13 ), and WNT signaling ( WIF1 ). We also experimentally validated a mutation in PIK3CD , a gene not previously implicated in lymphomas. The patterns of mutation demonstrated a classic long tail distribution with substantial variation of mutated genes from patient to patient and also between published studies. Thus, our study reveals the tremendous genetic heterogeneity that underlies lymphomas and highlights the need for personalized medicine approaches to treating these patients.

8 May 2014 in Blood
Verified
Journal Article
Open access
PDF file
JZJenny Zhang
Jenny Zhang
DJDereje Jima
Dereje Jima
AMAndrea B. Moffitt
Andrea B. Moffitt
QLQingquan Liu
Qingquan Liu
MCMagdalena Czader
Magdalena Czader
SDSandeep S. Dave
Sandeep S. Dave
Key Points: We identified novel recurrently mutated genes, including WHSC1, RB1, POT1, and SMARCA4, through exome sequencing of 56 cases of MCL. Genetic mutations defining MCL and Burkitt lymphoma were associated with the epigenetically defined chromatin state of their respective B cells of origin.

7 May 2009 in Blood
Verified
Journal Article
Closed access
PDF file
JZJenny Zhang
Jenny Zhang
DJDereje Jima
Dereje Jima
CJCassandra Jacobs
Cassandra Jacobs
RFRandy Fischer
Randy Fischer
EGEva Gottwein
Eva Gottwein
SDSandeep S. Dave
Sandeep S. Dave
Mature B-cell differentiation provides an important mechanism for the acquisition of adaptive immunity. Malignancies derived from mature B cells constitute the majority of leukemias and lymphomas. These malignancies often maintain the characteristics of the normal B cells that they are derived from, a feature that is frequently used in their diagnosis. The role of microRNAs in mature B cells is largely unknown. Through concomitant microRNA and mRNA profiling, we demonstrate a potential regulatory role for microRNAs at every stage of the mature B-cell differentiation process. In addition, we have experimentally identified a direct role for the microRNA regulation of key transcription factors in B-cell differentiation: LMO2 and PRDM1 (Blimp1). We also profiled the microRNA of B-cell tumors derived from diffuse large B-cell lymphoma, Burkitt lymphoma, and chronic lymphocytic leukemia. We found that, in contrast to many other malignancies, common B-cell malignancies do not down-regulate microRNA expression. Although these tumors could be distinguished from each other with use of microRNA expression, each tumor type maintained the expression of the lineage-specific microRNAs. Expression of these lineage-specific microRNAs could correctly predict the lineage of B-cell malignancies in more than 95% of the cases. Thus, our data demonstrate that microRNAs may be important in maintaining the mature B-cell phenotype in normal and malignant B cells.

1 June 2019 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
SRSarah E. Reese
Sarah E. Reese
CXCheng-Jian Xu
Cheng-Jian Xu
HDHerman T. Den Dekker
Herman T. Den Dekker
MLMi Kyeong Lee
Mi Kyeong Lee
SSSinjini Sikdar
Sinjini Sikdar
SLStephanie London
Stephanie London
Epigenetic mechanisms, including methylation, can contribute to childhood asthma. Identifying DNA methylation profiles in asthmatic patients can inform disease pathogenesis. We sought to identify differential DNA methylation in newborns and children related to childhood asthma. Within the Pregnancy And Childhood Epigenetics consortium, we performed epigenome-wide meta-analyses of school-age asthma in relation to CpG methylation (Illumina450K) in blood measured either in newborns, in prospective analyses, or cross-sectionally in school-aged children. We also identified differentially methylated regions. In newborns (8 cohorts, 668 cases), 9 CpGs (and 35 regions) were differentially methylated (epigenome-wide significance, false discovery rate < 0.05) in relation to asthma development. In a cross-sectional meta-analysis of asthma and methylation in children (9 cohorts, 631 cases), we identified 179 CpGs (false discovery rate < 0.05) and 36 differentially methylated regions. In replication studies of methylation in other tissues, most of the 179 CpGs discovered in blood replicated, despite smaller sample sizes, in studies of nasal respiratory epithelium or eosinophils. Pathway analyses highlighted enrichment for asthma-relevant immune processes and overlap in pathways enriched both in newborns and children. Gene expression correlated with methylation at most loci. Functional annotation supports a regulatory effect on gene expression at many asthma-associated CpGs. Several implicated genes are targets for approved or experimental drugs, including IL5RA and KCNH2. Novel loci differentially methylated in newborns represent potential biomarkers of risk of asthma by school age. Cross-sectional associations in children can reflect both risk for and effects of disease. Asthma-related differential methylation in blood in children was substantially replicated in eosinophils and respiratory epithelium.

2 December 2010 in Blood
Verified
Journal Article
Closed access
PDF file
DJDereje Jima
Dereje Jima
JZJenny Zhang
Jenny Zhang
CJCassandra Jacobs
Cassandra Jacobs
KRKristy L. Richards
Kristy L. Richards
CDCherie H. Dunphy
Cherie H. Dunphy
F(for the Hematologic Malignancies Research Consortium (HMRC)
for the Hematologic Malignancies Research Consortium (HMRC)
A role for microRNA (miRNA) has been recognized in nearly every biologic system examined thus far. A complete delineation of their role must be preceded by the identification of all miRNAs present in any system. We elucidated the complete small RNA transcriptome of normal and malignant B cells through deep sequencing of 31 normal and malignant human B-cell samples that comprise the spectrum of B-cell differentiation and common malignant phenotypes. We identified the expression of 333 known miRNAs, which is more than twice the number previously recognized in any tissue type. We further identified the expression of 286 candidate novel miRNAs in normal and malignant B cells. These miRNAs were validated at a high rate (92%) using quantitative polymerase chain reaction, and we demonstrated their application in the distinction of clinically relevant subgroups of lymphoma. We further demonstrated that a novel miRNA cluster, previously annotated as a hypothetical gene LOC100130622, contains 6 novel miRNAs that regulate the transforming growth factor-β pathway. Thus, our work suggests that more than a third of the miRNAs present in most cellular types are currently unknown and that these miRNAs may regulate important cellular functions.